Business Value Center Biotech

we are experienced in valuing biotech companies. we understand value at stages, patient cliff and spin-offs based on patents. our valuations are recognized by the irs, sba, banks and merger and acquisition professionals. we perform valuations of 100% of the company and of non-controlling, minority shares. we are accredited by the national association of certified analysts (nacva), a credential that requires demonstrated business experience, training, continuing education and peer review of a case study prior to credentialing.